• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Health Canada Issues Recalls of Taisho Pharma

    HEALTH CANADA

    Biolinq and Taisho Pharmaceutical Announce Strategic Collaboration

    BUSINESSWIRE

    Jupiter Wellness Reports Second Quarter 2022 Financial Results

    ACCESSWIRE

    Jupiter Wellness Licenses Minoxidil Booster to Taisho

    ACCESSWIRE

    Elixirgen Tx Partners with Taisho Pharma on Aging-Associated Diseases

    PRNEWSWIRE

    Joe Jimenez`s Ancora Bio poaches Sage CMO to revive Taisho drug

    FIERCEBIOTECH

    Chugai Pharma, Taisho Pharma terminate co-marketing agreement for Edirol

    PHARMABIZ

    Insilico, Taisho form AI collab to tackle age-related diseases

    FIERCE BIOTECH

    Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery

    PRNEWSWIRE

    BioAge Signs Exclusive License Agreement Taisho Taisho’s Ph1 HIF-PH Inhibitor

    GLOBENEWSWIRE

    Moberg Pharma and Taisho Sign Exclusive License Agreement for MOB-015 in Japan

    BIOSPACE

    Bristol-Myers Squibb Completes Divestment of UPSA

    BIOSPACE

    Chugai Pharma receives Japanese approval for steoporosis drug, Bonviva tablet

    PHARMABIZ

    Vernalis plc Enters Into Research Collaboration With Taisho Pharmaceutical Co., Ltd

    VERNALIS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.